Our findings provide strong evidence that the down-regulation of miRNA-221-5p increased IL-6, IL-17, IL-21 and IL-22 levels, and reduced IL-10, IL-35 and TGF-β levels in vitro model of asthma. This evidence concerns the gene IL17A and asthma.